152 related articles for article (PubMed ID: 22654229)
21. The prevalence and determinants of complementary medicine use for nigerian children in the Turkish Republic of Northern Cyprus.
Christopher GO; Ozturk C
Niger J Clin Pract; 2020 Aug; 23(8):1054-1060. PubMed ID: 32788481
[TBL] [Abstract][Full Text] [Related]
22. The use of complementary and alternative medicine by patients with cancer: in Turkey.
Akyol AD; Oz B
Complement Ther Clin Pract; 2011 Nov; 17(4):230-4. PubMed ID: 21982139
[TBL] [Abstract][Full Text] [Related]
23. Complementary and alternative medicine among Singapore cancer patients.
Chow WH; Chang P; Lee SC; Wong A; Shen HM; Verkooijen HM
Ann Acad Med Singap; 2010 Feb; 39(2):129-35. PubMed ID: 20237735
[TBL] [Abstract][Full Text] [Related]
24. The use of complementary and alternative medicine by patients with cancer: a cross-sectional survey in Saudi Arabia.
Abuelgasim KA; Alsharhan Y; Alenzi T; Alhazzani A; Ali YZ; Jazieh AR
BMC Complement Altern Med; 2018 Mar; 18(1):88. PubMed ID: 29530034
[TBL] [Abstract][Full Text] [Related]
25. Complementary and alternative medicine use in oncology: a questionnaire survey of patients and health care professionals.
Chang KH; Brodie R; Choong MA; Sweeney KJ; Kerin MJ
BMC Cancer; 2011 May; 11():196. PubMed ID: 21609461
[TBL] [Abstract][Full Text] [Related]
26. The status of alternative treatment in cancer patients in Turkey.
Isikhan V; Komurcu S; Ozet A; Arpaci F; Ozturk B; Balbay O; Guner P
Cancer Nurs; 2005; 28(5):355-62. PubMed ID: 16192826
[TBL] [Abstract][Full Text] [Related]
27. The use of complementary and alternative medicine (CAM) therapies by Turkish women with gynecological cancer.
Yildirim Y; Tinar S; Yorgun S; Toz E; Kaya B; Sonmez S; Balsak D
Eur J Gynaecol Oncol; 2006; 27(1):81-5. PubMed ID: 16550977
[TBL] [Abstract][Full Text] [Related]
28. Complementary and alternative medicine use by gynecologic oncology patients in Turkey.
Nazik E; Nazik H; Api M; Kale A; Aksu M
Asian Pac J Cancer Prev; 2012; 13(1):21-5. PubMed ID: 22502670
[TBL] [Abstract][Full Text] [Related]
29. Use of complementary and alternative medicine by patients with cancer in Saudi Arabia.
Jazieh AR; Al Sudairy R; Abulkhair O; Alaskar A; Al Safi F; Sheblaq N; Young S; Issa M; Tamim H
J Altern Complement Med; 2012 Nov; 18(11):1045-9. PubMed ID: 22906212
[TBL] [Abstract][Full Text] [Related]
30. Patterns of the use of complementary and alternative medicine in women with metastatic cancer.
Yildirim Y
Cancer Nurs; 2010; 33(3):194-200. PubMed ID: 20357652
[TBL] [Abstract][Full Text] [Related]
31. Complementary and alternative medicine in cancer patients - analysis of influencing factors in Turkey.
Malak AT; Karayurt O; Demir E; Yümer AS
Asian Pac J Cancer Prev; 2009; 10(6):1083-7. PubMed ID: 20192589
[TBL] [Abstract][Full Text] [Related]
32. Use of complementary and alternative medicine by patients with cancer: a cross-sectional study at different points of cancer care.
Wortmann JK; Bremer A; Eich HT; Wortmann HP; Schuster A; Fühner J; Büntzel J; Muecke R; Prott FJ; Huebner J
Med Oncol; 2016 Jul; 33(7):78. PubMed ID: 27300549
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and correlates of complementary and alternative medicine use among cancer patients in usmanu danfodiyo university teaching hospital, Sokoto, Nigeria.
Aliyu UM; Awosan KJ; Oche MO; Taiwo AO; Jimoh AO; Okuofo EC
Niger J Clin Pract; 2017 Dec; 20(12):1576-1583. PubMed ID: 29378990
[TBL] [Abstract][Full Text] [Related]
34. Perception of cancer patients of their disease, self-efficacy and locus of control and usage of complementary and alternative medicine.
Ebel MD; Rudolph I; Keinki C; Hoppe A; Muecke R; Micke O; Muenstedt K; Huebner J
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1449-55. PubMed ID: 25702103
[TBL] [Abstract][Full Text] [Related]
35. Complementary and alternative medicine (CAM) among hospitalised patients: an Australian study.
Shorofi SA; Arbon P
Complement Ther Clin Pract; 2010 May; 16(2):86-91. PubMed ID: 20347839
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and determinants of using complementary and alternative medicine for the treatment of chronic illnesses: A multicenter study in Bangladesh.
Shahjalal M; Chakma SK; Ahmed T; Yasmin I; Mahumud RA; Hossain A
PLoS One; 2022; 17(1):e0262221. PubMed ID: 34986159
[TBL] [Abstract][Full Text] [Related]
37. Complementary and alternative medicine use in breast cancer patients in Europe.
Molassiotis A; Scott JA; Kearney N; Pud D; Magri M; Selvekerova S; Bruyns I; Fernadez-Ortega P; Panteli V; Margulies A; Gudmundsdottir G; Milovics L; Ozden G; Platin N; Patiraki E
Support Care Cancer; 2006 Mar; 14(3):260-7. PubMed ID: 16143871
[TBL] [Abstract][Full Text] [Related]
38. Use of complementary and alternative medicine and quality of life of cancer patients who received chemotherapy in Turkey.
Irmak Z; Tanrıverdi Ö; Ödemiş H; Uysal DD
Complement Ther Med; 2019 Jun; 44():143-150. PubMed ID: 31126547
[TBL] [Abstract][Full Text] [Related]
39. Complementary and alternative medicine use in lung cancer patients in eight European countries.
Molassiotis A; Panteli V; Patiraki E; Ozden G; Platin N; Madsen E; Browall M; Fernandez-Ortega P; Pud D; Margulies A
Complement Ther Clin Pract; 2006 Feb; 12(1):34-9. PubMed ID: 16401528
[TBL] [Abstract][Full Text] [Related]
40. Is there any difference in the use of complementary and alternative therapies in patients asthma and COPD? A cross-sectional survey.
Argüder E; Bavbek S; Sen E; Köse K; Keskin O; Saryal S; Misirligil Z
J Asthma; 2009 Apr; 46(3):252-8. PubMed ID: 19373632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
